Advocate

Country: European Union

Language: Bulgarian

Source: EMA (European Medicines Agency)

Buy It Now

Active ingredient:

имидаклоприд, моксидектин

Available from:

Bayer Animal Health GmbH

ATC code:

QP54AB52

INN (International Name):

imidacloprid, moxidectin

Therapeutic group:

Dogs; Cats; Ferrets

Therapeutic area:

Антипаразитни продукти, инсектициди и репеленти

Therapeutic indications:

DogsFor кучета, страдащи или застрашени от смесени паразитни инфекции:лечение и профилактика на инвазия на бълхи (Ctenocephalides Фелиз),лечение на ухапване от въшки (Trichodectes Голям Canis),лечение на ушния акари паразитози (Otodectes cynotis), саркоптозе (причинена от Sarcoptes болест VAR. Голямо Куче), и demodectic краста (причинена от демодекс канис),профилактика на дирофилариоза болест (L3 и L4 ларви на сърдечни червеи),лечението с микрофилярии (сърдечни червеи),лечение на кожни dirofilariosis (полово зрели стадии дирофилярий пълзящи)за профилактика на кожни dirofilariosis (Л3 ларви дирофилярий влечуги),намалена с микрофилярии (сърдечни влечуги),профилактика на angiostrongylosis (Л4 ларви и незрели възрастни на Angiostrongylus vasorum),лечение на Angiostrongylus vasorum и Crenosoma vulpis,профилактика spirocercosis (Spirocerca лупи),лечение на Eucoleus (Syn. Capillaria) boehmi (за възрастни),за лечение на очите червей Thelazia callipaeda (за възрастни),за лечение на инфекции на стомашно-чревния тракт нематоди (Л4 ларви, незрели възрастни и възрастни Тохосага Canis, Ancylostoma сатпит и Uncinaria stenocephala, възрастни Toxascaris leonina и Trichuris vulpis). Продуктът може да се използва като част от стратегия за лечение на бълхата дерматит алергии (УСР). CatsFor котки, страдащи или застрашени от смесени паразитни инфекции:лечение и профилактика на инвазия на бълхи (Ctenocephalides Фелиз),лечение на ушния акари паразитози (Otodectes cynotis),лечение на notoedric краста (Notoedres cati в),лечение на lungworm Eucoleus aerophilus (Syn. Capillaria aerophila) (за възрастни),превенция на болестите lungworm (Л3/Л4 ларви Aelurostrongylus abstrusus),лечение на lungworm Aelurostrongylus abstrusus (за възрастни),за лечение на очите червей Thelazia callipaeda (за възрастни),профилактика на дирофилариоза болест (L3 и L4 ларви на сърдечни червеи),лечение на инфекции на стомашно-чревния тракт нематоди (Л4 ларви, незрели възрастни и възрастни Тохосага cati и паразитози Ancylostoma tubaeforme). Продуктът може да се използва като част от стратегия за лечение на бълхата дерматит алергии (УСР). FerretsFor порове, страдащи или застрашени от смесени паразитни инфекции:лечение и профилактика на инвазия на бълхи (Ctenocephalides Фелиз),профилактика на дирофилариоза болест (L3 и L4 ларви на сърдечни червеи).

Product summary:

Revision: 23

Authorization status:

упълномощен

Authorization date:

2003-04-02

Patient Information leaflet

                                OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Актуална информация за този
ветеринарен лекарствен продукт
можете да намерите на интернет
страницата с информация за
ветеринарните лекарствени продукти.
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Актуална информация за този
ветеринарен лекарствен продукт
можете да намерите на интернет
страницата с информация за
ветеринарните лекарствени продукти.
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Spanish 31-01-2024
Public Assessment Report Public Assessment Report Spanish 29-01-2024
Patient Information leaflet Patient Information leaflet Czech 31-01-2024
Public Assessment Report Public Assessment Report Czech 29-01-2024
Patient Information leaflet Patient Information leaflet Danish 31-01-2024
Public Assessment Report Public Assessment Report Danish 29-01-2024
Patient Information leaflet Patient Information leaflet German 31-01-2024
Public Assessment Report Public Assessment Report German 29-01-2024
Patient Information leaflet Patient Information leaflet Estonian 31-01-2024
Public Assessment Report Public Assessment Report Estonian 29-01-2024
Patient Information leaflet Patient Information leaflet Greek 31-01-2024
Public Assessment Report Public Assessment Report Greek 29-01-2024
Patient Information leaflet Patient Information leaflet English 31-01-2024
Public Assessment Report Public Assessment Report English 29-01-2024
Patient Information leaflet Patient Information leaflet French 31-01-2024
Public Assessment Report Public Assessment Report French 29-01-2024
Patient Information leaflet Patient Information leaflet Italian 31-01-2024
Public Assessment Report Public Assessment Report Italian 29-01-2024
Patient Information leaflet Patient Information leaflet Latvian 31-01-2024
Public Assessment Report Public Assessment Report Latvian 29-01-2024
Patient Information leaflet Patient Information leaflet Lithuanian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Lithuanian 31-01-2024
Public Assessment Report Public Assessment Report Lithuanian 29-01-2024
Patient Information leaflet Patient Information leaflet Hungarian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Hungarian 31-01-2024
Public Assessment Report Public Assessment Report Hungarian 29-01-2024
Patient Information leaflet Patient Information leaflet Maltese 31-01-2024
Public Assessment Report Public Assessment Report Maltese 29-01-2024
Patient Information leaflet Patient Information leaflet Dutch 31-01-2024
Public Assessment Report Public Assessment Report Dutch 29-01-2024
Patient Information leaflet Patient Information leaflet Polish 31-01-2024
Public Assessment Report Public Assessment Report Polish 29-01-2024
Patient Information leaflet Patient Information leaflet Portuguese 31-01-2024
Summary of Product characteristics Summary of Product characteristics Portuguese 31-01-2024
Public Assessment Report Public Assessment Report Portuguese 29-01-2024
Patient Information leaflet Patient Information leaflet Romanian 31-01-2024
Public Assessment Report Public Assessment Report Romanian 29-01-2024
Patient Information leaflet Patient Information leaflet Slovak 31-01-2024
Public Assessment Report Public Assessment Report Slovak 29-01-2024
Patient Information leaflet Patient Information leaflet Slovenian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Slovenian 31-01-2024
Public Assessment Report Public Assessment Report Slovenian 29-01-2024
Patient Information leaflet Patient Information leaflet Finnish 31-01-2024
Public Assessment Report Public Assessment Report Finnish 29-01-2024
Patient Information leaflet Patient Information leaflet Swedish 31-01-2024
Public Assessment Report Public Assessment Report Swedish 29-01-2024
Patient Information leaflet Patient Information leaflet Norwegian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Norwegian 31-01-2024
Public Assessment Report Public Assessment Report Norwegian 29-01-2024
Patient Information leaflet Patient Information leaflet Icelandic 31-01-2024
Summary of Product characteristics Summary of Product characteristics Icelandic 31-01-2024
Public Assessment Report Public Assessment Report Icelandic 29-01-2024
Patient Information leaflet Patient Information leaflet Croatian 31-01-2024
Public Assessment Report Public Assessment Report Croatian 29-01-2024

View documents history